Long term use of proton pump inhibitors and risk of stomach cancer: population based case-control study in five Nordic countries
Long term proton pump inhibitor use may not be associated with an increased risk of gastric adenocarcinoma.
Authors
- Giola B. Santoni
- Dag Holmberg (ORCID: https://orcid.org/0000-0003-1000-5422)
- von Euler-Chelpin M
- Onyinyechi Duru
- Helgi Birgisson
- J Lagergren
- Joonas H Kauppila
- Eivind Ness-Jensen
Institutions
- University of Copenhagen (DK)
- Karolinska University Hospital (SE)
- King's College London (GB)
- Norwegian University of Science and Technology (NO)
- Oulu University Hospital (FI)
- Levanger Hospital (NO)
- Karolinska Institutet (SE)
- Icelandic Cancer Society (IS)
- University of Oulu (FI)
Publication Details
- Journal
- BMJ
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1136/bmj-2025-086384
- Citations
- 1
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 33.53